PFIZER INC: Appealing Norvasc Patent Invalidity Ruling in Canada
Pfizer Inc. is pursuing an appeal to the Canadian Federal Court in Toronto’s declaration that its amlodipine besylate patent is invalid.
Certain generic manufacturers are seeking to market generic amlodipine products…